New shockwave therapy can treat underlying issues related with Erectile Dysfunction and Peyronie’s Disease

GAINSWave™ uses shockwaves to stimulate vascularization and improve penile function.

Go to the profile of RegMedNet
Mar 24, 2017

A new therapy is now available that uses high frequency sound waves to stimulate blood vessel growth and support blood flow to the male anatomy. GAINSWave™ aims to treat Erectile Dysfunction (ED) and Peyronie’s Disease by causing cellular microtrauma, which in turn stimulates the release of angiogenic factors and the subsequent neovascularization of the treated tissue. This therapy will be utilized by Rejuvenate Image Restoration (CA, USA) to treat.

“This is truly a regenerative medicine treatment and not a temporary solution as in the case of oral medications, prosthetic rings and injections. It treats the underlying cause of ED which is compromised blood flow to the penis and can improve sexual performance in men of all ages,” commented Bertica M. Rubio (staff physician, Rejuvenate Image Restoration).

Nearly 50% of men over the age of 40 have some degree of ED and 80% of these cases go unreported. Peyronie’s Disease—also referred to as penile fibrosis—is a medical condition in which scar tissue (plaque) forms in the penis, causing it to bend or curve. The plaque buildup can cause significant pain and sexual dysfunction in men, thus interfering with their daily lives and causing unwarranted embarrassment.

Low-intensity extracorporeal shock wave therapies such as GAINSWave™ have been shown to generate significant clinical improvement of erectile function without any adverse effects. However, the exact mechanism of action of the treatment is not well understood so further clinical trials are required before this treatment can be used more widely.

Sources: Gruenwald I, Appel B, Kitrey ND, Vardi Y. Shockwave treatment of erectile dysfunction. Ther. Adv. Urol. 5(2): 95–99 (2013);

Go to the profile of RegMedNet


eCommunity, Future Science Group

RegMedNet is a networking site where users can share their knowledge and insights. This profile will share some content and updates from the RegMedNet team, including webinars, news and journal articles.

No comments yet.